[Hyperprolactinemia: importance of early therapy].
Rachidi-Koussa
H
H
Vergely
N
N
Duthel
R
R
Malluret
J
J
Estour
B
B
D000236:Adenoma / Q000150:complications* / Q000378:metabolism; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000150:complications*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy / Q000209:etiology*; D009364:Neoplasm Recurrence, Local; D010911:Pituitary Neoplasms / Q000150:complications* / Q000378:metabolism; D013997:Time Factors; D001615:beta-Endorphin / Q000378:metabolism*
D001971:Bromocriptine; D001615:beta-Endorphin
Hyperprolactinémie: attention aux thérapeutiques hâtives.